U.S. market Closed. Opens in 10 hours 16 minutes

KALV | KalVista Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-12-312015-04-302014-12-312013-12-312012-12-31
RevenueN/AN/AN/A12.69M12.69M16.13M8.39M1.50M2.13M29.00K1.80M29.00K415.00K1.54M
Cost of Revenue86.17M802.00K743.00K651.00K40.19K35.02KN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-86.17M-802.00K-743.00K12.04M12.65M16.09M8.39MN/AN/AN/AN/AN/AN/AN/A
Operating Expenses54.28M110.87M96.61M57.92M53.22M45.95M27.10M23.84MN/A21.07MN/AN/AN/AN/A
Selling, General & Admin54.28M30.59M26.45M16.64M13.03M10.93M8.86M11.18M2.65M4.87M1.61M3.41M1.40M1.41M
Research & Development86.17M80.28M70.17M41.29M40.19M35.02M18.24M12.67M14.66M16.20M8.29M8.29M4.23M1.96M
Other Operating Expenses-86.17M15.64M14.72M9.93M9.83M7.68MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-140.44M-110.87M-96.61M-57.92M-40.53M-29.82M-18.70M-22.34M-15.18M-21.04M-8.09M-11.68M-5.22M-1.83M
Other Expenses / Income13.80M17.96M14.27M11.68M11.29M7.73M2.90M3.74M3.75M-3.81M863.00K-1.68M-462.00K-220.00K
Before Tax Income-126.64M-92.91M-82.34M-46.24M-29.24M-20.69M-15.80M-18.60M-11.44M-24.85M-7.23M-13.36M-5.68M-2.05M
Income Tax Expenses-8.45M-18.05M-13.83M-1.75M-124.00K124.00K-1.33MN/AN/AN/AN/AN/AN/AN/A
Net Income-126.64M-74.85M-68.51M-44.49M-29.12M-20.82M-15.80M-18.60M-11.44M-24.85M-7.23M-13.36M-5.68M-2.05M
Interest ExpensesN/A-17.96M1.09MN/AN/A-9.18M-2.90MN/AN/A1.19MN/A1.08M405.00K256.00K
Basic Shares Outstanding36.79M27.89M24.47M19.09M17.75M15.08M10.32M4.65M591.30K1.36M263.36K724.80K2.33M724.80K
Diluted Shares Outstanding36.79M27.89M24.47M19.09M17.75M15.08M10.32M4.65M591.30K1.36M263.36K724.80K2.33M724.80K
EBITDA-139.63M-110.24M-94.51M-58.23M-39.65M-29.49M-16.95M-18.56M-11.40M-23.52M-7.19M-12.22M-5.25M-1.76M
EBITDA Margin0.00%0.00%0.00%-458.89%-312.48%-182.87%-201.94%-1,234.24%-534.60%-81,120.69%-398.45%-42,148.28%-1,264.10%-114.37%
EBIT-135.10M-110.87M-81.25M-46.24M-29.24M-29.87M-20.03M-18.60M-11.44M-23.66M-7.23M-12.28M-5.27M-1.80M
EBIT Margin0.00%0.00%0.00%-364.41%-230.42%-185.21%-238.63%-1,236.90%-536.15%-81,579.31%-400.55%-42,334.48%-1,270.60%-116.84%
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-12-312015-04-302014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙